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Allergic diseases are typically characterized by an exacerbated immune response against allergens, leading to T H 2 polarization and production of allergen-specific IgE. Despite recent advances, the early events leading to allergic sensitization and the elicitation of T H 2 immune responses are still unclear. Dendritic cells (DCs) are specialized antigen-presenting cells that play an important role in the induction and re-elicitation of T H 2 allergic immune responses. [1] [2] [3] [4] Recent work by us and others has shown that C-type lectin receptors (CLRs), such as mannose receptor (MR) and dendritic cell-specific intracellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN), play a major role in the recognition and uptake of allergens, the initial steps leading to allergic sensitization. 1, [5] [6] [7] [8] [9] [10] Interestingly, under certain conditions, DC-SIGN and MR ligation can have opposing effects on T-cell polarization. 5, 6 MR is a multifunctional endocytic receptor with 2 independent carbohydrate-binding domains that recognize sulfated and mannosylated structures, respectively. 11 Several studies have demonstrated that CLR activation can modulate pattern recognition receptor-induced activation, particularly Toll-like receptor 4 (TLR4) signaling, and the downstream events leading to T H 2 cell polarization. 1, 5, [12] [13] [14] [15] [16] We have previously shown that Der p 1, the main allergen from house dust mite (HDM), in the presence of low levels of LPS downregulates indoleamine 2,3-dioxygenase (IDO) through engagement of MR on human DCs, leading to a T H 2 immune response. 5 These data show the involvement of MR in inducing T H 2 allergic immune responses through regulation of IDO activity in human DCs with the participation of TLR4 signaling; however, the exact mechanism remains unclear.
IDO is an enzyme that catalyzes the degradation of the essential amino acid tryptophan (TRP) into N-formyl-kynurenine, the first and rate-limiting step of TRP catabolism in the kynurenine (KYN) pathway. 17, 18 IDO has been demonstrated to be involved in diverse immunoregulatory processes in both health and disease. 17, 18 In particular, it has been shown that IDO has a protective role in several models of experimental asthma. [19] [20] [21] [22] [23] [24] Furthermore, clinical studies have shown that asymptomatic nonatopic subjects have higher systemic IDO activity than symptomatic atopic subjects, which might support the notion of IDO as a protector against allergy. 25, 26 However, the mechanism of IDO regulation in these models, particularly in a human context, has remained elusive.
Aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor involved in sensing intracellular or 27 KYN, one of the main metabolites produced in the IDO-dependent TRP degradation pathway, can activate AhR, leading to generation of regulatory T cells. 28 In addition, previous observations in mouse DCs have suggested that AhR mediates IDO induction in response to TLR agonists. 29, 30 Here we sought to investigate how allergens modulate the crosstalk between MR and TLR4 in the context of IDO and to establish whether AhR plays a role in IDO regulation in human DCs. We have demonstrated that different airborne allergens, most likely through binding to MR, can significantly downregulate TLR4 induction of IDO and impair the DC response to LPS, as evidenced by suppression of IL-12 production and priming T H 1 responses. Furthermore, for the first time, we show coregulation of AhR and components of the noncanonical nuclear factor kB (NF-kB) pathway with IDO expression, suggesting that a functional and/or physical association between them could be involved in IDO regulation in human DCs. These data further highlight the intrinsic immunomodulatory properties of allergens through engagement with CLRs and can help us to better understand how allergens can modulate DC behavior and bias T-cell responses toward the T H 2 immune phenotype.
METHODS

Generation of human DCs from blood samples
Buffy coat samples were obtained from healthy volunteers after obtaining written informed consent and approval of the local ethics committee (National Blood Service, Sheffield, United Kingdom). DCs were generated, as described previously. 5, 31 Briefly, PBMCs were separated by means of density gradient centrifugation on Histopaque (Sigma-Aldrich, St Louis, Mo). CD14
1 monocytes were isolated from PBMCs by means of positive selection with a magnetic cell separation system (Miltenyi Biotech, Woking, United Kingdom; purity >95%) and then seeded in RPMI 1640 medium (Sigma-Aldrich) supplemented with 10% vol/vol heat-inactivated FBS, 100 U/mL penicillin, 100 mg/ mL streptomycin, and 2 mmol/L L-glutamine (all from Sigma-Aldrich). Monocyte differentiation into DCs was carried out for 6 days in the presence of 50 ng/mL GM-CSF and 250 U/mL IL-4 (both from Miltenyi Biotech). Human peripheral blood myeloid DCs were isolated by using the CD1c 1 Dendritic Cell Isolation Kit (Miltenyi Biotech), according to the manufacturer's instructions.
Quantification of IDO activity
DCs (2.5 3 10 5 cells/mL) were seeded in a 24-well plate with complete media supplemented with 100 mmol/L L-TRP (Sigma-Aldrich). After stimulation, IDO activity was measured by means of quantification of KYN levels in the culture supernatant by using a colorimetric assay, as described previously. 5 Allergen extracts were purchased from Greer Laboratories (Lenoir, NC). Typical endotoxin content of HDM preparations was 26.1 EU/mg protein.
Flow cytometric analysis
Antibodies against IFN-g (clone B27), IL-4 (clone MP4-25D2), and MR (clone 19.2) were purchased from BioLegend (London, United Kingdom). Antibodies against CD80 (clone MAB104), CD83 (clone HB15a), CD86 (clone HA5.2B7), MHC class II (clone Immu-357), CD4 (clone 13B8.2), and DC-SIGN (clone AZND1) were purchased from Beckman coulter (High Wycombe, United Kingdom). Antibodies against PDL2 (clone MIH18), PDL1 (clone MIH1), and ICOSL (clone 2D3/B7-H2) were purchased from BD Biosciences (San Jose, Calif). Antibody against AhR (clone FF3399) was purchased from eBioscience (Hatfield, United Kingdom). Antibody against IDO1 (clone 700838) was purchased from R&D Systems (Abingdon, United Kingdom). Antibody against TLR4 (clone HTA125) was purchased from AbD Serotec (Kidlington, United Kingdom). Nonreactive isotype-matched antibodies were used as controls. Briefly, cells were harvested and washed twice with PBS containing 0.5% BSA and 0.1% sodium azide (all from SigmaAldrich). At this point, surface staining was done for 20 minutes at 48C. For intracellular staining, cells were fixed for 10 minutes at room temperature with formaldehyde 4% (Sigma-Aldrich). They were then washed twice with permeabilization/wash buffer (PBS containing 0.5% BSA and 0.1% sodium azide with 0.5% saponin, Sigma-Aldrich), stained for 30 minutes at 48C, and washed twice in the same buffer before analysis in an FC 500 Flow Cytometer (Beckman Coulter). 32 mRNA isolation, cDNA synthesis, and PCR Cells were washed twice in ice-cold PBS, and total RNA extraction was carried out with the RNeasy Plus Minikit (Qiagen, Manchester, United Kingdom), according to the manufacturer's instructions. Samples were then DNase treated with the TURBO DNA-free kit (Thermo Fisher Scientific, Waltham, Mass), and total RNA was concentrated through ethanol precipitation. cDNA was synthesized from total RNA by using the SuperScript III First-Strand Synthesis Kit (Thermo Fisher Scientific), according to the manufacturer's instructions.
Conventional PCR was carried out in a TC-312 PCR Thermocycler (Bibby Scientific, Stone, United Kingdom) by using the Phusion Flash High-Fidelity PCR Master Mix (Thermo Fisher Scientific). Cycling was initiated at 988C for 10 seconds, followed by 30 cycles of 988C for 1 second, 648C for 5 seconds, and 728C for 15 seconds; the final extension was done at 728C for 1 minute. Then the PCR products were analyzed in an E-Gel Precast 2% Agarose Electrophoresis System (Thermo Fisher Scientific).
Quantitative real-time PCR was performed in a Strategene MxPro 3005P qPCR System with the Brilliant III Ultra-Fast SYBR Green qPCR Master Mix (Agilent Technologies, Santa Clara, Calif). Cycling was initiated at 958C for 3 minutes, followed by 40 cycles of 958C for 20 seconds and 608C for 20 seconds, and a melting curve was done at the end. Samples were run in triplicates, and relative expression was calculated by using the comparative threshold cycle method, also known as the DD cycle threshold method normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 33, 34 Primers were obtained from Eurofins (Luxembourg): GAPDH forward 
Cytokine measurements
Cell-free supernatants were collected and stored at 2208C before analysis. Cytokine (IL-6, IL-10, IL-12p70, TGF-b, and IFN-a) concentrations were analyzed by using the ProcartaPlex Multiplex Immunoassay system (eBioscience), according to the manufacturer's instructions. IFN-g levels were measured using the DuoSet ELISA System (R&D Systems), according to manufacturer's instructions.
RNA interference
Small interfering RNA (siRNA) analysis was carried out as previously described with slight modification. 5, 6 MR and AhR siRNA were the SMARTpool:ON-TARGETplus siRNA from GE Healthcare (Little Chalfont, United Kingdom). The control siRNA was the ON-TARGETplus Nontargeting control from GE Healthcare. Monocytes were transfected on day 0 with 50 nmol/L siRNA by using the DharmaFECT 2 Transfection Reagent (GE Healthcare). Inhibition was assessed at day 6.
Reverse phase protein microarray
After stimulation, DCs were washed twice with ice-cold PBS and lysed in 60 mL of RIPA buffer containing protease and phosphatase inhibitors (all from Thermo Fisher Scientific). For the reverse phase protein microarray, the procedure described by Negm et al 35 was followed. After denaturation, samples were spotted onto nitrocellulose-coated glass slides (Grace Bio-Labs, Bend, Ore) with a microarray robot (MicroGrid 610; Digilab, Marlborough, Mass). Then slides were incubated overnight in blocking solution (0.2% I-Block [Thermo Fisher Scientific] and 0.1% Tween-20 in PBS [Sigma-Aldrich]) at 48C. After washing, slides were incubated with primary antibodies overnight at 48C. b-Actin antibody was included as a loading control. All antibodies were purchased from Cell Signaling Technologies (Danvers, Mass). After washing, slides were incubated with infrared Licor secondary antibodies for 30 minutes at room temperature in the dark. Finally, slides were scanned with a Licor Odyssey scanner (LI-COR Biosciences, Lincoln, Neb). The resultant TIFF images were processed with GenePix Pro-6 Microarray Image Analysis software (Molecular Devices, Sunnyvale, Calif). Protein signals were finally determined by using background subtraction and normalization to the internal housekeeping targets. Signal values represented on the color scale for the heat map are log 2 transformed from arbitrary fluorescence units and normalized by using the SD. Heat maps were generated with TMEV software.
DC/T-cell coculture
Human DCs were treated or not with mannan from Saccharomyces cerevisiae (10 mg/mL, Sigma-Aldrich) and cocultured in the presence of LPS (0.01 mg/mL, Sigma-Aldrich) in 96-well U-bottom plates (Corning Life Sciences, Tewksbury, Mass) with CD3
1 CD45RA 1 autologous naive T cells (DC/ T-cell ratio 1:10) purified by means of immunomagnetic cell sorting (Miltenyi Biotech) in RPMI 1640 supplemented with 5% human AB serum, 100 U/mL penicillin, 100 mg/mL streptomycin, and 2 mmol/L L-glutamine (all from Sigma-Aldrich). After 3 to 4 days, IL-2 (5 ng/mL, R&D Systems) with fresh media was added to the coculture. After another 3 to 4 days, T cells were restimulated with anti-CD3 (Sigma-Aldrich) and anti-CD28 (2 mg/mL) for 18 hours (AbD Serotec). For intracellular staining, brefeldin-A (10 mg/mL, Sigma-Aldrich) was added after 2 hours, and production of IL-4 and IFN-g was detected on CD4 1 cells by using specific antibodies. Quadrants were set in a way that 99.5% of the cells were in the bottom or left quadrant in the fluorescence minus one controls accordingly.
Statistical analysis
Means 6 SEMs are shown, unless otherwise stated. ANOVA or the Student t test was applied. For all statistical analysis, GraphPad Prism 5 software (GraphPad Software, La Jolla, Calif) was used.
RESULTS
TLR4 agonist induce IDO1 and IDO2 in human DCs
Our data clearly show that LPS on its own can effectively induce expression of both IDO isozymes (IDO1 and IDO2) and IDO activity in human monocyte-derived DCs, as well as in peripheral blood myeloid DCs (Fig 1) . This is in contrast to previous reports in which costimulation with either IFN-g or prostaglandin E 2 was deemed to be essential. [36] [37] [38] [39] Additionally, this effect was observed with LPS from different bacterial sources, such as Escherichia coli and Salmonella minnesota (Fig 1, A, and data not shown). Some LPS preparations are thought to be contaminated with small quantities of other bacterial components that could also activate TLR2 signaling. To confirm that the outcome on IDO was mediated by TLR4 engagement, we tested the effect of ultrapure LPS, as well as the synthetic diacylated lipoprotein fibroblast-stimulating lipopeptide-1 (FSL-1), as a specific TLR2 agonist. Our data showed similar dose-dependent effects induced by increasing concentrations of ultrapure LPS (Fig 1, B) , whereas FSL-1 did not affect IDO activity in human DCs (data not shown). Interestingly, our data also show a bellshaped dose response for IDO activity after TLR4 activation with LPS from E coli, with high levels (10 mg/mL) inducing less IDO activity than low levels (0.1 mg/mL) in human DCs. However, this was not the case for ultrapure LPS, in which we observed a dose-dependent induction of IDO activity in human DCs. The effect of LPS was not associated with cell death because high levels of LPS did not affect cell viability, as quantified by the presence of annexin-V and propidium iodine (data not shown).
TLR4 induction of IDO1 and IDO2 is downregulated by allergens from diverse sources
After establishing the role of LPS in IDO regulation, we investigated how different allergen extracts (ie, HDM extract from Dermatophagoides pteronyssinus, German cockroach extract from Blattella germanica, and Bermuda grass pollen extract from Cynodon dactylon) can modulate IDO activity in the presence and absence of LPS. A slight downregulation in IDO activity levels was observed when human DCs were exposed to allergen extracts alone, but this did not reach statistical significance. However, allergen extracts from HDM, cockroach, and pollen were able to significantly reduce LPS-driven upregulation of IDO in human DCs (Fig 2, A) .
We have previously shown that many allergens from diverse sources (including HDM and cockroach) are heavily mannosylated 7 and that such sugar moieties play a key role in CLR-mediated allergen recognition and uptake by DCs. 1, 7 Accordingly, we studied the effect of highly mannosylated sugars in IDO regulation by using mannan as a prototypical highmannose carbohydrate that can be recognized by MR. 40, 41 Here we have shown that mannan is able to downregulate both IDO1 and IDO2 gene expression and activity in human DCs (Fig 2, B  and C) . These data suggest a key role for carbohydrates in allergen preparations in modulating IDO in human DCs.
Mannose-based ligands downregulate TLR4-induced IL-12p70 production in human DCs and affect T helper cell polarization Several cytokines have been linked with IDO regulation. In particular, IL-10, TGF-b, and type I interferons have been associated with IDO induction, 18, 25, 42 whereas IL-6 has been shown to be involved in IDO degradation. 18 Additionally, it has been suggested that specific MR agonists, such as the mannose-capped lipoarabinomannans, can negatively regulate TLR4-dependent IL-12 production in mouse macrophages. 43 Accordingly, we studied how these cytokines are regulated by mannan in human DCs. No significant differences were found when DCs were stimulated with mannan alone compared with unstimulated DCs (data not shown). However, the presence of mannan significantly reduced IL-12p70 production after LPS stimulation compared with LPS alone (Fig 3, A) . Similar results were found after stimulating DCs with LPS in the presence of HDM, cockroach, and pollen extracts (Fig 3, B) . Subsequently, we evaluated how different costimulatory receptors were regulated under these conditions. No significant differences were found for most of the receptors tested, except a significant downregulation in CD86 expression (Fig 3, C) .
We then performed coculture experiments with DCs prestimulated with either mannan, LPS, or both before coculture with autologous naive T cells. Our data show a significant reduction in IFN-g production by T cells that were cocultured with mannan plus LPS-primed DCs compared with LPS-only control cells (Fig  3, D-F) . This reduction in IFN-g levels was not due to reduced cell viability and was reflected in both percentages of IFNg-producing cells and levels of IFN-g measured in the culture supernatant (Fig 3, D and E) . Given the nonatopic status of donors, not surprisingly, we did not detect high levels of IL-4-producing T cells except in 1 donor in whom there was a significant increase in the percentage of IL-4-producing cells under mannan plus LPS conditions (data not shown). Taken together, these results show that allergen extracts and mannan can downregulate IDO in DCs and suppress T H 1 polarization.
MR mediates IDO downregulation by mannosebased ligands
Because MR is not the only receptor involved in the recognition of mannosylated structures on DCs, we sought to determine the role of MR in mannan-mediated modulation of IDO activity in human DCs. Using siRNA, we could knock down MR expression on DCs by up to 80%, similar to our previous work (see Fig E1 in this article's Online Repository at www.jacionline.org). 5 Control dendritic cells (CT-DCs) and MR low -DCs were stimulated with mannan with or without LPS, and IDO activity was measured after 24 hours of culture. These data clearly show an increase in IDO (Fig 4, A) . Additionally, we found an inverse correlation between MR and IDO1 expression in DCs stimulated with mannan and LPS (Fig 4, B) . A reduction in IDO1 levels was associated with an increase in MR expression in DCs stimulated with mannan. These data suggest that mannosylated allergens downregulate IDO through MR engagement in human DCs.
IDO regulation in human DCs is partially dependent on AhR
To study the role of the receptor transcription factor AhR in the induction of IDO in human DCs, we generated AhR low -DCs through gene silencing (see Fig E2 in this article' s Online Repository at www.jacionline.org) and analyzed IDO activity after TLR4 stimulation compared with that seen in CT-DCs. Our data show a lack of IDO upregulation in AhR low -DCs compared with CT-DCs after TLR4 engagement (Fig 5, A) , which suggests that LPS-mediated IDO induction in human DCs is partially dependent on AhR expression. Accordingly, we next sought to evaluate how AhR expression and activity were regulated after stimulating DCs with mannan in the presence and absence of LPS. When DCs were stimulated with mannan and LPS, AHR expression and activity, as assessed by measuring the expression of one of its target genes (ie, CYP1A1), were significantly reduced compared with those in DCs stimulated with LPS alone (Fig 5, B) . This shows that MR engagement can interfere with TLR4 signaling by modulating the AhR-IDO axis in human DCs.
Furthermore, we found that IL-10 production and IDO activity were significantly lower in AhR low -DCs than in CT-DCs, whereas production of IL-12p70, a key cytokine involved in T H 1 polarization, was not affected (Fig 5, C) . For the first time, these data show the important role of AhR in TLR4 signaling in human DCs, specifically in their regulatory functions, such as those mediated by IDO and IL-10 production.
The NF-kB pathway is negatively regulated by MR in human DCs
The NF-kB pathway plays a central role in driving immunity and inflammation. TLR4 signaling induces the canonical NF- kB   FIG 2. A, IDO activity in DCs stimulated for 24 hours with allergen extracts (10 mg/mL) and LPS (0.01 mg/mL; n > _ 4). BGP, Bermuda grass pollen; GC, German cockroach. B, IDO activity in DCs stimulated for 24 hours with mannan (M; 10 mg/mL) and LPS (n 5 5). C, IDO1/IDO2 gene expression in DCs stimulated for 24 hours with mannan and LPS (n 5 3). In costimulation experiments cells were stimulated with LPS, followed immediately by allergen extracts. **P < _ .01, ***P < _ .001, and ****P < _ .0001.
pathway, resulting in p65 phosphorylation, nuclear translocation, and induction of proinflammatory cytokine expression, which activate the immune response. 44 On the other hand, IDO induction has been shown to be under the control of the noncanonical NF-kB pathway 36, 42, 45 involving the generation of p52-RelB complexes. 44, 46 Accordingly, we evaluated how MR modulates both the canonical and noncanonical NF-kB pathway in human DCs. To understand how different components of the NF-kB pathway were regulated on TLR4 activation (in the presence and absence of mannan), we used a reverse phase protein array approach 35 that enables simultaneous evaluation of protein expression, as well as posttranslational modifications. First, we evaluated a panel of 14 different targets at different time points (10, 30, 90, 360 , and 1080 minutes) by using b-actin as a housekeeping control. Green (low expression) to red (high expression) heat maps represent the relative abundance of proteins upstream of the canonical and noncanonical NF-kB signaling pathway (Fig 6, A) . DCs stimulated with LPS exhibited a rapid induction in p65 phosphorylation, with a peak at 90 minutes (canonical NF-kB activation), which was followed by NF-kB-inducing 1 cells (n 5 3). *P < _ .05, **P < _ .01, and ***P < _ .001.
FIG 4. A, IDO activity in CT-DCs and MR
low -DCs stimulated with mannan (M) and LPS for 24 hours. B, MR and IDO1 protein expression in DCs stimulated with mannan and LPS for 24 hours. Median fluorescence intensity (MFI) values were normalized by using a control unstimulated sample (n 5 3). *P < _ .05, **P < _ .01, and ****P < _ .0001.
kinase (NIK) accumulation at between 6 to 18 hours (a classical indicator of non-canonical NF-kB activation; Fig 6, A and B) . However, mannan on its own did not induce NF-kB activation (data not shown). Main differences were found in the levels of phospho-p65, as well as the expression of RelB, in DCs stimulated with mannan plus LPS compared with LPS only (Fig 6, A-C) . DCs stimulated with mannan and LPS showed a significant decrease in a component of the noncanonical NF-kB pathway, namely RelB (Fig 6, B and C) , which was further confirmed at the gene level by using quantitative RT-PCR (Fig 6, D) . In addition, a decrease was observed in phospho-p65 levels at late time points (Fig 6, B and C) . Taken together, these data show that MR ligation in human DCs impairs NF-kB activation in the presence of LPS. This antagonistic effect of MR on TLR4 activation of the noncanonical NF-kB pathway could explain the effect on the AhR-IDO axis described above, which perhaps might involve a physical and functional association between AhR and RelB in modulating IDO levels in human DCs.
DISCUSSION
Asthma is a common chronic inflammatory disease of the conducting airways that affects millions of persons worldwide. Allergic asthma is characterized by T H 2 cell differentiation and the presence of IgE antibodies against common inhaled allergens. DCs have been shown to be pivotal in the early events, such as allergen recognition and uptake, which lead to T H 2 polarization and ultimately allergic sensitization; however, how allergens modulate DC functions and downstream T-cell responses is not clear. [1] [2] [3] [4] Previous observations have shown that TLR4 signaling is crucial for inducing T H 2-mediated inflammation and asthma, [47] [48] [49] which is dependent on the levels of LPS exposure. 49 Therefore it is reasonable to assume that allergens could potentially modulate the DC response to LPS in favor of T H 2 responses. LPS-induced programming of human DCs is characterized by a rapid increase in proinflammatory cytokine levels, followed by induction of anti-inflammatory mediators that help resolve inflammation. One of the key molecules that mediate immunoregulatory function in DCs is the TRP-metabolizing enzyme IDO. 17, 18 In this study we first established how IDO is regulated in human DCs in response to the TLR4 agonist LPS, showing IDO upregulation in response to relatively low concentrations of LPS (up to 100 ng/mL), followed by a reduction in IDO expression at higher concentrations (Fig 1) . These data were confirmed after using ultrapure LPS, establishing involvement of the TLR4 pathway only (Fig 1, B) . Two IDO isozymes have been identified, namely IDO1 and IDO2, 50 with IDO1 being the most extensively studied. Both genes have similar structures and are situated adjacent to each other on human chromosome 8. Although both proteins have similar enzymatic activity, there are different expression patterns in some pathological conditions. [51] [52] [53] Here, for the first time, we have shown that both IDO isozymes are induced after TLR4 engagement (Fig 1, D) .
We and others have previously shown that CLRs, such as MR and DC-SIGN, are key receptors involved in allergen recognition by DCs and in downstream events leading to T H 2 cell polarization. 1, 5, 6, 8, 10, 54 In the case of MR, this is likely to be mediated through downregulation of IDO activity 5 ; however, the molecular mechanisms of how MR ligation modulates IDO activity remained unclear. In the current study, using siRNA (see Fig E1) , we have shown that MR mediates the allergen (and mannan)-induced downregulation of IDO activity in LPS-stimulated DCs (Fig 4) . These data demonstrate the ability of a number of clinically relevant allergen extracts from diverse sources, such as HDM, cockroach, and pollen, in downregulating LPS-induced IDO activity and the importance of carbohydrates in this process (Fig 2) . Admittedly, not all allergens are necessarily glycosylated (eg, lipocalins); however, it is still worth investigating IDO regulation by such families of allergens given their proved ability in enhancing innate immune signaling by modulating TLR4 activation. 55, 56 Furthermore, we studied how MR engagement might modulate other aspects of DC function. Our data showed that mannosylated sugars can particularly downregulate production of TLR4-mediated IL-12p70, a key cytokine in T H 1 polarization (Fig 3,  A) . This shows an antagonistic effect between MR and TLR4, which was in line with previous observations. 41, 43, 57, 58 A similar pattern was found with all the allergen extracts tested, suggesting that the mannosylated sugars on them are responsible for modulation of IL-12p70 production (Fig 3, B) . In terms of costimulatory molecules, we found a significant downregulation in CD86 levels in DCs stimulated with mannan (Fig 3, C) . It is interesting to note that CD86 is one of the B7 family proteins that has been previously associated with IDO induction. 59, 60 Furthermore, we have shown that MR engagement by mannan impairs T H 1 cell priming induced by LPS, as evidenced by a significant suppression in IFN-g production, which could bias T-cell responses toward a T H 2 profile (Fig 3, D-F) . These data clearly suggest that reduction in IDO, through MR, could promote T H 2 immune responses.
IDO has been well defined for its role in T H 1 cell-mediated immune responses; however, its role in T H 2 immune responses, particularly in human subjects, has remained controversial. 61 Some studies have shown that IDO can have a protective effect in different models of experimental asthma. [19] [20] [21] [22] [23] [24] This is in line with clinical studies showing that asymptomatic nonatopic subjects have higher systemic IDO activity than symptomatic atopic subjects. 25, 26 Paradoxically, IDO expression might also contribute to mediation of inflammatory responses in patients with established T H 2-mediated airway diseases. For example, a study with IDO knockout mice demonstrated that lack of IDO provides a significant relief from establishment of allergic airway disease, 62 which could be due to impaired DC function in IDOdeficient DCs. 63, 64 AhR is a ligand-dependent transcription factor and a member of the Per-Arnt-Sim (PAS) superfamily of proteins, which are involved in detection of environmental or intracellular changes. The interaction of AhR with aryl hydrocarbon receptor nuclear translocator protein allows it to bind specific enhancer sequences present in target promoters called dioxin-responsive elements. 27 Previously, AhR has been shown to have a protective role in allergy. [65] [66] [67] [68] Accordingly, in an attempt to elucidate the mechanism of TLR4-and MR-mediated IDO modulation, we studied the potential link between AhR and IDO in human DCs. Here we have shown that TLR4-mediated induction of IDO is partially dependent on AhR expression (Fig 5, A) . In addition, we have shown that the anti-inflammatory cytokine IL-10 is under the control of AhR, which highlights a central role for AhR in modulating DCmediated immune suppression/regulation (Fig 5, C) . Furthermore, we demonstrated that MR can downregulate AhR expression and activity in the presence of LPS in human DCs (Fig 5, B) , which could explain its effect on IDO expression (Fig 4) and suppression of T H 1 responses (Fig 3) . Interestingly, it has been shown that exogenous AhR ligands, such as 2,3,7,8-tetrachlorodibenzodioxin, can impair DC phenotype and function, [68] [69] [70] [71] [72] suppressing allergic sensitization. 66, 68 Furthermore, metabolites produced in the IDOdependent TRP degradation pathway, such as KYN and kynurenic acid, can activate AhR, leading to regulatory T or T H 17 cell differentiation depending on the immunologic context. 28, [73] [74] [75] Accordingly, we can speculate that IDO metabolites can have disparate effects in allergic responses, which will require further investigation.
IDO induction has been shown to be under the control of the noncanonical NF-kB pathway. 36, 42, 45 Additionally, NF-kB, together with AhR, has been shown to be pivotal in TLR4 signaling. 44, [76] [77] [78] Therefore we evaluated the role of the NF-kB pathway in IDO regulation by MR. Using a protein microarray approach, 35 we evaluated the expression of key components of the NF-kB pathway after stimulation with LPS in the presence and absence of mannan. Our data showed that stimulation with mannan and LPS can significantly downregulate some key components of the noncanonical NF-kB pathway, such as RelB, as well as the canonical NF-kB pathway, such as phospho-p65 (Fig 6) . Although a signaling motif has not been identified in the MR cytoplasmic domain, members of the NF-kB signaling pathway have been previously implicated in MR-mediated signaling. 43, 79 For instance, mannose-capped lipoarabinomannans, most likely through binding to MR, mediate IL-1 receptor-associated kinase M (IRAK-M) induction, which acts as a negative regulator of the NF-kB pathway. 43 Interestingly, our preliminary data also show that mannan stimulation reduces IRAK-M expression in the presence of LPS in human DCs (data not shown), which is in line with previous observations showing that IRAK-M might protect against complications of asthma because T H 2 cytokines decrease IRAK-M expression in macrophages. 80 Collectively, these observations highlight the role of the NF-kB pathway in MR-mediated IDO regulation in DCs. It is important to note that KYN, through the AhR/suppressor of cytokine signaling 2-dependent pathway, can induce proteasome-mediated degradation of TNF receptor-associated factor 6, which might potentially inhibits TLR signaling, favoring the noncanonical NF-kB pathway. 81 Additionally, an association between AhR and RelB has been suggested [82] [83] [84] that might contribute to the stabilization of RelB complexes. 85, 86 Accordingly, it is reasonable to suggest that AhR together with RelB might be involved in IDO regulation in human DCs, a pathway that experiences interference after MR engagement. Future studies should aim at elucidating the potential physical association between AhR and RelB in regulating IDO levels.
In conclusion, we have demonstrated that diverse airborne allergens can downregulate IDO after TLR4 engagement and that this effect was mainly mediated by MR. In addition, we have showed that AhR and RelB are implicated in MR-mediated IDO downregulation, suggesting a new pathway involved in inserting the immunoregulatory properties of allergens (Fig 7) . These data provide new insight into the initial steps of allergic sensitization, which could pave the way for developing more effective therapeutic strategies targeting early events in the allergic cascade.
